• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The measurement of left ventricular ejection fraction (LVEF) is a ubiquitous component of
imaging studies used to evaluate patients with cardiac conditions and acts as an arbiter for …

Background Risk stratification for ventricular arrhythmias (VA) and sudden death in
nonischemic dilated cardiomyopathy (DCM) remains suboptimal. Objectives The goal of this …

Aims Myocardial scar detected by cardiovascular magnetic resonance has been associated
with sudden cardiac death in dilated cardiomyopathy (DCM). Certain genetic causes of DCM …

Background This study assessed the prevalence of left ventricular (LV) involvement and
characterized the clinical, electrocardiographic, and imaging features of LV phenotype in …

Background The left atrium is an early sensor of left ventricular (LV) dysfunction. Still, the
prognostic value of left atrial (LA) function (strain) on cardiac magnetic resonance (CMR) in …

Cardiovascular diseases (CVDs) remain a major global health challenge, leading to
significant morbidity and mortality while straining healthcare systems. Despite progress in …

Background: Genetic analysis is a first-tier test in dilated cardiomyopathy (DCM). Electrical
phenotypes are common in genetic DCM, but their exact contribution to the clinical course …

Objectives The aim of this study is to examine the prognostic value of T1 mapping and the
extracellular volume (ECV) fraction in patients with dilated cardiomyopathy (DCM) …

Artificial intelligence (AI) is entering the clinical arena, and in the early stage, its
implementation will be focused on the automatization tasks, improving diagnostic accuracy …